The Department of Medicine is proud to announce that Stony Brook University Hospital has been nationally recognized as an approved NPF Center by the National Pancreas Foundation. NPF Centers are awarded after a rigorous audit review to determine that an institution's focus is on multidisciplinary treatment of pancreatitis, treating the “whole patient”, with a focus on the best possible outcomes and an improved quality of life.
“We are thrilled to expand our NPF Centers of Excellence Program to better serve the needs of patients suffering from pancreas disease,” said David Bakelman, CEO of the National Pancreas Foundation. “The NPF Centers of Excellence Program is one of the pillars of NPF, and we are looking forward to working with our current and new Centers.”
An approved NPF Center has to meet the criteria that were developed by a task force made up of invited subject matter experts and patient advocates. The criteria includes having the required expert physician specialties such as gastroenterologists, pancreas surgeons, and interventional radiologists, along with more patient-focused programs such as a pain management service, psychosocial support and more.
"This new recognition is the result of our institution's quality collaborative care for patients with benign pancreatic diseases among our practitioners in the Departments/Divisions of HPB Surgery, Interventional Radiology, Nutrition, Psychology, Pain Management, Pathology, and Gastroenterology. I am proud of our 'Pancreatitis Group' for achieving this distinction, and it provides further fuel to the ongoing efforts of Dr. Sasson and I as we further develop our multi-specialty ambulatory clinic in benign pancreatic disease."
- Jonathan M. Buscaglia, M.D., FASGE, AGAF, Division Chief, Gastroenterology and Hepatology, Professor, Department of Medicine and Director, Advanced Endoscopy Program, Stony Brook University Hospital, Stony Brook Medicine
Founded in 1997, the National Pancreas Foundation provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting-edge research, advocating for new and better therapies and providing support and education for patients, caregivers and healthcare professionals. The NPF is the only foundation dedicated to patients suffering from all forms of pancreas disease.
The Department of Medicine is thrilled and honored to share the news of this critical collaboration. We congratulate Dr. Buscaglia and the gastroenterology team, as well as the entire partnership of practitioners, who have tirelessly contributed to this remarkable achievement.
